Raffles Medical Group (RMG)

RHB upgrades Raffles Medical to 'buy' on return to business as usual - THE EDGE SINGAPORE

Broker's Calls

RHB upgrades Raffles Medical to 'buy' on return to business as usual

RHB analyst Shekhar Jaiswal expects the group to deliver over 25% in profit growth over the next two years.
Founders of Raffles Medical Group and Credit Bureau Asia raise respective stakes - THE EDGE SINGAPORE

Founders of Raffles Medical Group and Credit Bureau Asia raise respective stakes

Founders of Raffles Medical Group and Credit Bureau Asia raise respective stakes, IPC Corp gets a new substantial shareholder.
Raffles Medical Group posts 9.3% higher FY20 earnings of $65.9 mil thanks to new services such as PCR testing - THE EDGE SINGAPORE

Results

Raffles Medical Group posts 9.3% higher FY20 earnings of $65.9 mil thanks to new services such as PCR testing

The group has declared a final dividend of 2.0 cents, and adds that it expects to remain profitable in FY2021.

Healthcare

Raffles Medical might have gone regional but Covid war brings it back to the homefront

Dr Loo Choon Yong, chairman of Raffles Medical Group, says he has never experienced a crisis like the Covid-19 pandemic in his half a century as a healthcare professional.

Broker's Calls

PhillipCapital remains neutral on Raffles Medical, says current downturn 'does not represent' business environment

PhillipCapital is maintaining its “neutral” call on Raffles Medical with a revised target price of 94 cents. This is down 5 cents or 5.05% from its previous 99 cent call, analyst Tay Wee Kuang says in a July 29 note.

Investing ideas

Analysts remain cautious on Raffles Medical as it remains infectious from Covid-19

Analysts are maintaining a cautious stance on Raffles Medical Group following the announcement of its 1H2020 results on July 27.

Results

Raffles Medical posts 38.2% drop in 1H2020 earnings, but expects to "remain profitable" this year

Earnings of healthcare provider Raffles Medical Group plunged 38.2% to $17.2 million for 1H2020 ended June, from $27.9 million a year ago, following the deferment of elective surgeries and a dip in foreign patients during the circuit breaker period.

Broker's Calls

Raffles Medical kept at 'neutral' as Singapore operations flatline

Raffles Medical kept at 'neutral' as Singapore operations flatline

Results

Raffles Medical posts 45.5% lower 1Q earnings of $7.5 mil on Covid-19 impact in China, Hong Kong

Raffles Medical Group (RMG) has announced earnings of $7.5 million for 1Q2020 ended March, down 45.4% y-o-y from $13.7 million.

Broker's Calls

Analysts remain neutral on Raffles Medical as it copes with the flu bug

Raffles Medical Group has caught “a common cold, not flu” say DBS analysts Rachel Tan and Andy Sim
×